Myambutol Related Clinical Trials
Effect of Weight and/or Obesity on Ethambutol Drug Concentrations [Completed]
Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis [Completed]
A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [Completed]
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [Completed]
Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis [Recruiting]
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [Completed]
A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients [Completed]
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS [Completed]
Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis [Recruiting]
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB [Not yet recruiting]
Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography [Completed]
A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults [Completed]
Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [Completed]
Improving Retreatment Success (IMPRESS) [Recruiting]
Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation [Recruiting]
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [Completed]
Research on New Regimens for Retreatment Pulmonary Tuberculosis [Recruiting]
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB [Active, not recruiting]
Early Bactericidal Activity (EBA) Study of Tuberculosis Regimens With and Without INH and Moxifloxacin [Recruiting]
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [Completed]
Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [Completed]
Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis [Recruiting]
Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Active, not recruiting]
Tuberculosis Treatment Shortening Trial [Completed]
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance [Completed]
TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment [Completed]
PK Study of Anti-TB Drugs [Not yet recruiting]
Latency in Pulmonary Tuberculosis [Recruiting]
Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis [Completed]
REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment [Active, not recruiting]
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 [Recruiting]
Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis [Active, not recruiting]
Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Active, not recruiting]
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes [Recruiting]
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis [Completed]
Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [Completed]
The Treatment of Tuberculosis in HIV-Infected Patients [Completed]
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [Completed]
Shortening Treatment by Advancing Novel Drugs [Recruiting]
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens [Not yet recruiting]
Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis [Completed]
TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Completed]
Assessing PA-824 for Tuberculosis (the APT Trial) [Recruiting]
Preventive Therapy for Tuberculosis in HIV Infected Persons [Active, not recruiting]
Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Recruiting]
A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. [Recruiting]
TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Completed]
Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [Completed]
Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease [Recruiting]
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Completed]
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [Completed]
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [Completed]
Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana [Recruiting]
Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) [Recruiting]
Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV [Recruiting]
Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan [Active, not recruiting]
High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study [Recruiting]
HRZE Fasted/Fed in Newly Diagnosed TB [Completed]
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) [Completed]
Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou [Recruiting]
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Recruiting]
A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections [Completed]
Study of Daily Rifapentine for Pulmonary Tuberculosis [Completed]
Treatment of Mycobacterium Xenopi Pulmonary Infection [Recruiting]
Use of Azithromycin and Rifabutin Administered Three Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease [Active, not recruiting]
Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients [Recruiting]
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection [Not yet recruiting]
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy [Recruiting]
Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs [Recruiting]
Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis [Completed]
Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis [Completed]
The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study [Active, not recruiting]
Optimization of the TB Treatment Regimen Cascade [Recruiting]
Trial of Antimycobacterial Therapy in Sarcoidosis [Active, not recruiting]
Phase 2a EBA Trial of AZD5847 [Completed]
A Study Of PNU-100480 In Newly Diagnosed, Treatment Sensitive Patients With Pulmonary Tuberculosis To Assess Early Bactericidal Activity (EBA) And Whole Blood Activity (WBA) [Completed]
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study [Completed]
An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) [Recruiting]
Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients [Completed]
Trial of High-Dose Rifampin in Patients With TB [Active, not recruiting]
The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases [Recruiting]
|